Literature DB >> 6215241

Current therapy for intermittent claudication.

M Verstraete.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215241     DOI: 10.2165/00003495-198224030-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  51 in total

Review 1.  Vasodilator drugs in peripheral vascular disease.

Authors:  J D Coffman
Journal:  Am J Hosp Pharm       Date:  1975-12

2.  High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-/total cholesterol ratio.

Authors:  S C Enger; K Herbjørnsen; J Erikssen; A Fretland
Journal:  Scand J Clin Lab Invest       Date:  1977-05       Impact factor: 1.713

Review 3.  Thrombolytic therapy is arterial thromboembolism.

Authors:  M Martin
Journal:  Prog Cardiovasc Dis       Date:  1979 Mar-Apr       Impact factor: 8.194

4.  Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency.

Authors:  A G Dahllöf; P Björntorp; J Holm; T Scherstén
Journal:  Eur J Clin Invest       Date:  1974-02       Impact factor: 4.686

5.  [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].

Authors:  H Ehringer; E Dudczak; K Lechner; F Widhalm
Journal:  Verh Dtsch Ges Inn Med       Date:  1972

6.  Effect of physical training on different categories of patients with intermittent claudication.

Authors:  T Jonason; B Jonzon; I Ringqvist; A Oman-Rydberg
Journal:  Acta Med Scand       Date:  1979

7.  Exercise and intermittent claudication.II. Effect of physical training.

Authors:  J S Skinner; D E Strandness
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

8.  The collateral circulation in occlusions of the femoral artery: an experimental study.

Authors:  P P Waibel; G Wolff
Journal:  Surgery       Date:  1966-10       Impact factor: 3.982

9.  The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities.

Authors:  J M Malone; W S Moore; J Goldstone
Journal:  Arch Surg       Date:  1975-11

10.  Controlled trial of suloctidil in intermittent claudication.

Authors:  R Verhaeghe; A Van Hoof; G Beyens
Journal:  J Cardiovasc Pharmacol       Date:  1981 Mar-Apr       Impact factor: 3.105

View more
  6 in total

1.  Pentoxifylline in arterial disease of the legs.

Authors:  R Verhaeghe; M Verstraete
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Pharmacological approaches to the treatment of intermittent claudication.

Authors:  E G Bevan; P C Waller; L E Ramsay
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

3.  Claudication.

Authors:  V C Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

4.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 5.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

Review 6.  Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.

Authors:  S P Clissold; S Lynch; E M Sorkin
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.